Blincyto

E2041326 UNEXPLORED

Blincyto is a bispecific T-cell engager (BiTE) immunotherapy used to treat certain types of B-cell acute lymphoblastic leukemia by directing the immune system to attack cancer cells.

Try in SPARQL Jump to: Surface forms Referenced by

All labels observed (1)

Label	Occurrences
Blincyto canonical	1

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Amgen → product → Blincyto ⓘ